Bandingkan Harga & Kinerja Modernland Realty Tbk. (MDLN) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Modernland Realty Tbk. dan Tempo Scan Pacific Tbk.: Modernland Realty Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 626,65 M, volume 24 jam 670,4 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.590 (kapitalisasi pasar 11,36 T, volume 24 jam 1,77 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 18,1× kapitalisasi pasar Modernland Realty Tbk., dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (1,77 jt vs 670,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MDLN | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 626,65 M | 11,36 T |
Volume | 670,4 rb | 1,77 jt |
Lot | 6,7 rb | 17,71 rb |
Perputaran | 33,52 jt | 4,61 M |
Harga Rata-rata | 50 | 2.603,9 |
Nilai Transaksi | 33,52 jt | 4,61 M |
Harga Ekuilibrium Indikatif | 50 | 2.590 |
Volume Ekuilibrium Indikatif | 1 | 300 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Modernland Realty Tbk.
PT. Modernland Realty tbk (the Company) was established based on Notarial deed No. 15 dated 8 August 1983 of Hendra Karyadi, S.H. The Company operates in land acquisition and site development and in the sale and management of housing estate, buildings and offices. The company started its operations in 1989 with marketing houses in Tangerang Regency.
Selengkapnya di halaman MDLN →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
